APOTEX INC FDA Approval ANDA 209851

ANDA 209851

APOTEX INC

FDA Drug Application

Application #209851

Application Sponsors

ANDA 209851APOTEX INC

Marketing Status

None (Tentative Approval)001

Application Products

001POWDER;INTRAVENOUSEQ 750MG BASE/VIAL0PEMETREXED DISODIUMPEMETREXED DISODIUM

FDA Submissions

UNKNOWN; ORIG1TA2017-08-25STANDARD

Submissions Property Types

ORIG1Null31

TE Codes

001PrescriptionAP

CDER Filings

APOTEX INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209851
            [companyName] => APOTEX INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"PEMETREXED","activeIngredients":"PEMETREXED","strength":"EQ 750MG BASE\/VIAL","dosageForm":"INJECTABLE; IV (INFUSION)","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/25\/2017","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-08-25
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.